Growth Metrics

Ginkgo Bioworks Holdings (DNA) Total Non-Current Liabilities: 2020-2025

Historic Total Non-Current Liabilities for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $612.2 million.

  • Ginkgo Bioworks Holdings' Total Non-Current Liabilities fell 7.97% to $612.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $612.2 million, marking a year-over-year decrease of 7.97%. This contributed to the annual value of $644.8 million for FY2024, which is 18.59% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Total Non-Current Liabilities stood at $612.2 million for Q3 2025, which was up 2.02% from $600.1 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Total Non-Current Liabilities high stood at $780.3 million for Q1 2023, and its period low was $61.8 million during Q1 2021.
  • In the last 3 years, Ginkgo Bioworks Holdings' Total Non-Current Liabilities had a median value of $644.8 million in 2024 and averaged $667.3 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Total Non-Current Liabilities spiked by 535.75% in 2022, and later fell by 29.55% in 2023.
  • Ginkgo Bioworks Holdings' Total Non-Current Liabilities (Quarterly) stood at $367.8 million in 2021, then skyrocketed by 109.87% to $771.9 million in 2022, then fell by 29.55% to $543.8 million in 2023, then rose by 18.59% to $644.8 million in 2024, then fell by 7.97% to $612.2 million in 2025.
  • Its Total Non-Current Liabilities was $612.2 million in Q3 2025, compared to $600.1 million in Q2 2025 and $630.6 million in Q1 2025.